The Joint Corp. (United States)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US47973J1025
USD
8.45
0.18 (2.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Nutex Health, Inc.
Talkspace, Inc.
Precipio, Inc.
Aveanna Healthcare Holdings, Inc.
The Pennant Group, Inc.
The Joint Corp. (United States)
LifeMD, Inc.
Biodesix, Inc.
CareMax, Inc.
DocGo, Inc.
Invitae Corp.
Why is The Joint Corp. (United States) ?
1
High Management Efficiency with a high ROE of 17.91%
2
Company has a low Debt to Equity ratio (avg) at times
3
Positive results in Jun 25
  • RAW MATERIAL COST(Y) Fallen by -16% (YoY)
  • CASH AND EQV(HY) Highest at USD 53.9 MM
  • DEBT-EQUITY RATIO (HY) Lowest at -124.06 %
4
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -28.95%, its profits have risen by 44.8%
5
High Institutional Holdings at 85.31%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -28.95% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to The Joint Corp. (United States) should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is The Joint Corp. (United States) for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
The Joint Corp. (United States)
-26.84%
-1.00
42.94%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.16%
EBIT Growth (5y)
-39.54%
EBIT to Interest (avg)
3.11
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-1.14
Sales to Capital Employed (avg)
3.70
Tax Ratio
4.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
85.31%
ROCE (avg)
25.28%
ROE (avg)
17.91%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.25
EV to EBIT
-161.51
EV to EBITDA
56.15
EV to Capital Employed
-58.87
EV to Sales
1.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-28.80%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -16% (YoY

CASH AND EQV(HY)

Highest at USD 53.9 MM

DEBT-EQUITY RATIO (HY)

Lowest at -124.06 %

PRE-TAX PROFIT(Q)

At USD -0.49 MM has Grown at 83.34%

NET PROFIT(Q)

At USD -0.5 MM has Grown at 83.93%

-17What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD 4.75 MM

NET SALES(Q)

At USD 13.27 MM has Fallen at -56.15%

DEBTORS TURNOVER RATIO(HY)

Lowest at 22.39 times

OPERATING PROFIT(Q)

Lowest at USD -0.23 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -1.7 %

Here's what is working for The Joint Corp. (United States)
Pre-Tax Profit
At USD -0.49 MM has Grown at 83.34%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
At USD -0.5 MM has Grown at 83.93%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Cash and Eqv
Highest at USD 53.9 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -124.06 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -16% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for The Joint Corp. (United States)
Net Sales
At USD 13.27 MM has Fallen at -56.15%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely negative

Net Sales (USD MM)

Operating Cash Flow
Lowest at USD 4.75 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Operating Profit
Lowest at USD -0.23 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin
Lowest at -1.7 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Debtors Turnover Ratio
Lowest at 22.39 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio